Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Total Liabilities Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Total amount the company owes to creditors
Latest
$6.12B
↑ 101% above average
Average (9y)
$3.04B
Historical baseline
Range
High:$6.12B
Low:$1.40B
CAGR
+17.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $6.12B | +18.9% |
| 2023 | $5.15B | +21.5% |
| 2022 | $4.24B | +27.2% |
| 2021 | $3.33B | +8.7% |
| 2020 | $3.06B | +37.2% |
| 2019 | $2.23B | +23.3% |
| 2018 | $1.81B | +20.4% |
| 2017 | $1.50B | -3.5% |
| 2016 | $1.56B | +10.9% |
| 2015 | $1.40B | - |